Phoenix Life Sciences International Limited. (PLSI) Financial Statements (2024 and earlier)

Company Profile

Business Address 3000 LAWRENCE STREET
DENVER, CO 80205
State of Incorp. NV
Fiscal Year End February 28
Industry (SIC) 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

2/28/2019
2/28/2018
2/28/2017
2/29/2016
2/28/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1189
Cash and cash equivalents1189
Receivables 236236249258
Inventory, net of allowances, customer advances and progress billings    1,211
Inventory    1,211
Prepaid expense   142
Other undisclosed current assets    2
Total current assets:2362372571,623
Noncurrent Assets
Long-term investments and receivables    
Long-term investments    
Intangible assets, net (including goodwill)    
Intangible assets, net (excluding goodwill)    
Other undisclosed noncurrent assets    1
Total noncurrent assets:   1
TOTAL ASSETS:2362372571,624
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:518518513410
Other undisclosed accounts payable and accrued liabilities518518513410
Debt    
Other liabilities    
Due to related parties    
Other undisclosed current liabilities 27727726750
Total current liabilities:796796780460
Noncurrent Liabilities
Long-term debt and lease obligation 416333193195
Long-term debt, excluding current maturities 416333193195
Liabilities, other than long-term debt 390471398170
Derivative instruments and hedges, liabilities 390471398170
Other undisclosed noncurrent liabilities    1,222
Total noncurrent liabilities: 8068045911,587
Total liabilities:1,6011,5991,3712,046
Equity
Equity, attributable to parent, including:(1,365)(1,363)(1,114)(422)
Common stock    
Additional paid in capital17,78517,71117,70517,248
Accumulated deficit(19,150)(19,074)(18,819)(18,031)
Other undisclosed equity, attributable to parent 000361
Total equity:(1,365)(1,363)(1,114)(422)
TOTAL LIABILITIES AND EQUITY:2362372571,624

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

2/28/2019
2/28/2018
2/28/2017
2/29/2016
2/28/2015
Revenues 81 1824
Financial services revenue✕81(74) (170)
Cost of revenue   (6)(14)
Cost of goods and services sold   (18)(34)
Gross profit: 81 1210
Operating expenses(0)(36)(510)(2,381)
Other undisclosed operating income (loss) (81)74  
Operating loss:(0)(36)(497)(2,372)
Nonoperating expense(76)(80)(224)(166)
Investment income, nonoperating7(80)(224)(166)
Interest and debt expense(83)(137)(174)(102)
Loss from continuing operations:(160)(252)(895)(2,640)
Loss before gain (loss) on sale of properties:(160)(252)(895)(2,640)
Other undisclosed net income    
Net loss:(160)(252)(895)(2,640)
Other undisclosed net income (loss) attributable to parent 83(2)107(14,724)
Net loss available to common stockholders, diluted:(77)(255)(788)(17,364)

Comprehensive Income ($ in thousands)
Annual | Quarterly

2/28/2019
2/28/2018
2/28/2017
2/29/2016
2/28/2015
Net loss:(160)(252)(895)(2,640)
Comprehensive loss, net of tax, attributable to parent:(160)(252)(895)(2,640)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: